Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04382898
Title PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (PRO-MERIT)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors BioNTech SE
Indications

prostate adenocarcinoma

Therapies

BNT112 + Cemiplimab

BNT112

Age Groups: adult | senior
Covered Countries USA | DEU


No variant requirements are available.